A. Martin Lerner

Medicine · Health Sciences

38h-index6.3kcitations187works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral Infections and Immunology Research(41), Herpesvirus Infections and Treatments(30), Viral gastroenteritis research and epidemiology(20), Virus-based gene therapy research(17), Cytomegalovirus and herpesvirus research(17)

Publications186 total

Toward understanding covid-19 recovery: national institutes of health workshop on postacute covid-19
UNC Libraries·2023Open Access
Erratum for Markmann et al., “Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals”
mSphere·2021· 9 citedOpen Access
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals
mSphere·2021· 48 citedOpen Access
Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individuals
2021· 20 citedOpen Access
The COVID-19 Vaccination Debate: CoV-2 in Celiac Disease: A Pathogen or just along for the Ride?
International Journal of Celiac Disease·2021· 7 citedOpen Access
Antibody to Epstein-Barr Virus Deoxyuridine Triphosphate Nucleotidohydrolase and Deoxyribonucleotide Polymerase in a Chronic Fatigue Syndrome Subset
PLoS ONE·2012· 52 citedOpen Access
Dynamics of Semantic Recall in Younger and Older Adults (P02.049)
Neurology·2012
An update on the management of glandular fever (infectious mononucleosis) and its sequelae caused by Epstein–Barr virus (HHV-4): new and emerging treatment strategies
Virus Adaptation and Treatment·2010· 6 citedOpen Access
Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome
Virus Adaptation and Treatment·2010· 18 citedOpen Access
Validation of the energy index point score to serially measure the degree of disability in patients with chronic fatigue syndrome.
PubMed·2009· 7 cited
Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up.
PubMed·2007· 59 cited
Immunoassay with cytomegalovirus early antigens from gene products p52 and CM<sub>2</sub> (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome
Journal of Clinical Pathology·2007· 40 cited
The Role of Aluminum in Bacterial‐induced Colitis in Young IL‐10‐deficient Mice
Journal of Pediatric Gastroenterology and Nutrition·2006· 4 cited
Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome.
PubMed·2005· 17 cited
IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome.
PubMed·2004· 69 cited
IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2(UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome.
PubMed·2003· 28 cited
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Journal of Chronic Fatigue Syndrome·2003· 1.2k cited
A Small, Randomized, Placebo-Controlled Trial of the Use of Antiviral Therapy for Patients with Chronic Fatigue Syndrome
Clinical Infectious Diseases·2001· 24 citedOpen Access
Focal Nodular Hyperplasia in Children
Journal of Pediatric Gastroenterology and Nutrition·2001· 18 cited
Focal Nodular Hyperplasia in Children
Journal of Pediatric Gastroenterology and Nutrition·2001
page 1 of 10Next →

Frequent Co-authors

Milagros P. Reyes(9), Maxwell Finland(7), Jerome O. Klein(4), Safedin Beqaj(4), James T. Fitzgerald(4), J. L. Chason(3), Francis M. Wilson(3), David C. Nolan(3), James D. Cherry(3), Elizabeth Bailey(3), James R. Tillotson(2), Donald P. Levine(2), Forrest Smith(2), Priscilla Bills(2), Ann Ewalt(2), Robert G Deeter(2), Howard S. Levin(2), Lawrence R. Crane(2), M. R. El-Khatib(2), Carl B. Lauter(2)